Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.68 |
| ▸ | CA2 | P00918 | 1/20 | 0.68 |
| ▸ | CA9 | Q16790 | 1/20 | 0.68 |
| ▸ | HTR6 | P50406 | 7/20 | 0.66 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.56 |
| ▸ | F2 | P00734 | 3/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.55 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.55 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.55 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | LOX | P28300 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.50 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ALPL | P05186 | 1/20 | 0.47 |
| ▸ | ALPI | P09923 | 1/20 | 0.47 |
| ▸ | ALPG | P10696 | 1/20 | 0.47 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7175789 | 0.98 | CA1 (0.65) | CA1CA2CA9HTR6AKR1B1 | |
| Phosphonic Acid SCHEMBL28657855 | 0.89 | CA1 (0.57) | CA1CA2CA9HTR6AKR1B1 | |
| SCHEMBL11197940 | 0.88 | CA1 (0.55) | CA1CA2CA9HTR6AKR1B1 | |
| SCHEMBL13241574 | 0.88 | CA1 (0.55) | CA1CA2CA9HTR6AKR1B1 | |
| SCHEMBL10388568 | 0.88 | GAA (0.69) | CA1CA2CA9HTR6AKR1B1 | |
| SCHEMBL7190517 | 0.88 | CA1 (0.60) | CA1CA2CA9HTR6AKR1B1 | |
| SCHEMBL3249669 | 0.87 | HTR6 (0.73) | CA1CA2CA9HTR6AKR1B1 | |
| SCHEMBL3071825 | 0.85 | CA1 (0.68) | CA1CA2CA9HTR6AKR1B1 | |
| SCHEMBL29965319 | 0.85 | CA1 (0.68) | CA1CA2CA9HTR6AKR1B1 | |
| SCHEMBL7535415 | 0.84 | CA1 (0.52) | CA1CA2CA9HTR6AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 458 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240222600-A1 | ABSORBENT GLASS MAT BATTERY | CLARIOS GERMANY GMBH & CO. KG (DE) | 2024-07-04 | — | — | US | claimed |
| CN-115505100-B | Epoxy resin based on spirosilafluorene as framework, and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-115505099-B | Epoxy resin containing carbazole structure, and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-06-28 | — | — | CN | claimed |
| US-11936032-B2 | Absorbent glass mat battery | CPS TECHNOLOGY HOLDINGS LLC (US) | 2024-03-19 | — | — | US | claimed |
| WO-2023020538-A1 | SERIAL ORGANIC ELECTROLUMINESCENT DEVICE | 清华大学 | 2023-02-23 | — | — | WO | claimed |
| CN-115505099-A | Epoxy resin containing carbazole structure and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-12-23 | — | — | CN | claimed |
| CN-115505100-A | Epoxy resin based on spirosilafluorene as skeleton and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-12-23 | — | — | CN | claimed |
| CN-111943949-B | Organic compound, application thereof and organic electroluminescent device containing compound | 清华大学 | 2022-05-20 | — | — | CN | claimed |
| EP-2481760-B1 | INITIATOR SYSTEM FOR CATIONIC POLYMERIZATION AND POLYMERIZATION METHOD USING SAME | CHINA PETROLEUM & CHEM CORP (CN) | 2021-05-05 | — | — | EP | claimed |
| US-8577267-B2 | Transparent intermediate transfer members containing zinc oxide, polyarylsulfone, and polyetheramine | XEROX CORPORATION (US) | 2013-11-05 | — | — | US | claimed |
| US-8343934-B2 | Diverse lead compound autotaxin inhibitors | UNIVERSITY OF MEMPHIS (US) | 2013-01-01 | — | — | US | claimed |
| US-20120119160-A1 | TRANSPARENT INTERMEDIATE TRANSFER MEMBERS CONTAINING ZINC OXIDE, POLYARYLSULFONE, AND POLYETHERAMINE | XEROX CORPORATION (US) | 2012-05-17 | — | — | US | claimed |
| US-20110160148-A1 | Novel Diverse Lead Compound Autotaxin Inhibitors | THE UNIVERSITY OF MEMPHIS RESEARCH FOUNDATION (US) | 2011-06-30 | — | — | US | claimed |
| WO-2011002918-A1 | NOVEL DIVERSE LEAD COMPOUND AUTOTAXIN INHIBITORS | THE UNIVERSITY OF MEMPHIS RESEARCH FOUNDATION (US) | 2011-01-06 | — | — | WO | claimed |
| EP-1150979-A1 | HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2001-11-07 | — | — | EP | claimed |
| WO-2000047578-A1 | HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2000-08-17 | — | — | WO | claimed |
| EP-0165388-B1 | SHAPED ARTICLE AND COMPOSITE MATERIAL FOR ITS PREPARATION | Dansk Eternit-Fabrik A/S (DK) | 1989-09-27 | — | — | EP | claimed |
| JP-7271102-A | — | — | None | — | — | JP | disclosed |
| US-4072497-A | (5-Alkylureido-1,3,4-thiadiazol-2-yl-thio) acetic acid tert-butyl esters and herbicidal compositions and processes | SCHERING AKTIENGESELLSCHAFT (DT) | 1978-02-07 | — | — | US | disclosed |
| US-4069205-A | FROM BI- OR TRI-PHENYLENE SULFIDE, AROMATIC ETHER, AND ISOPHTHALOYL OR TEREPHTHALOYL HALIDE | UNIVERSITY PATENTS, INC. (US) | 1978-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160148-A1 | Novel Diverse Lead Compound Autotaxin Inhibitors | ENPP2, ABHD16A, PLAAT2 | CA1 1413/4885CA2 2203/4885CA9 2249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.